94 related articles for article (PubMed ID: 16857690)
21. Anti-tuberculosis drug resistance among retreatment patients seen at St Peter Tuberculosis Specialized Hospital.
Meskel DW; Abate G; Lakew M; Goshu S; Aseffa A
Ethiop Med J; 2008 Jul; 46(3):219-25. PubMed ID: 19271385
[TBL] [Abstract][Full Text] [Related]
22. Immune markers measured before treatment predict outcome of intensive phase tuberculosis therapy.
Brahmbhatt S; Black GF; Carroll NM; Beyers N; Salker F; Kidd M; Lukey PT; Duncan K; van Helden P; Walzl G
Clin Exp Immunol; 2006 Nov; 146(2):243-52. PubMed ID: 17034576
[TBL] [Abstract][Full Text] [Related]
23. Strain differentiation of Mycobacterium tuberculosis complex isolated from sputum of pulmonary tuberculosis patients.
Abbadi S; El Hadidy G; Gomaa N; Cooksey R
Int J Infect Dis; 2009 Mar; 13(2):236-42. PubMed ID: 18838283
[TBL] [Abstract][Full Text] [Related]
24. Efficiency of adaptive cluster sampling for estimating plant disease incidence.
Ojiambo PS; Scherm H
Phytopathology; 2010 Jul; 100(7):663-70. PubMed ID: 20528184
[TBL] [Abstract][Full Text] [Related]
25. Primary drug resistance in newly diagnosed smear positive tuberculosis patients in Addis Ababa, Ethiopia.
Asmamaw D; Seyoum B; Makonnen E; Atsebeha H; Woldemeskel D; Yamuah L; Addus H; Aseffa A
Ethiop Med J; 2008 Oct; 46(4):367-74. PubMed ID: 19271401
[TBL] [Abstract][Full Text] [Related]
26. The microbiological and clinical effects of combined therapy according to guidelines on the treatment of pulmonary Mycobacterium avium complex disease in Japan - including a follow-up study.
Kobashi Y; Matsushima T
Respiration; 2007; 74(4):394-400. PubMed ID: 16954651
[TBL] [Abstract][Full Text] [Related]
27. Repeated sputum microscopy is not essential for monitoring tuberculosis treatment response.
Shivakumar M; Prabhakarareddy B; Rajaprasannakumar A; Vijayakumaran P; Krishnamurthy P
Int J Tuberc Lung Dis; 2006 Nov; 10(11):1296-8. PubMed ID: 17131792
[TBL] [Abstract][Full Text] [Related]
28. A refined symptom-based approach to diagnose pulmonary tuberculosis in children.
Marais BJ; Gie RP; Hesseling AC; Schaaf HS; Lombard C; Enarson DA; Beyers N
Pediatrics; 2006 Nov; 118(5):e1350-9. PubMed ID: 17079536
[TBL] [Abstract][Full Text] [Related]
29. Factors influencing time to smear conversion in patients with smear-positive pulmonary tuberculosis.
Wang JY; Lee LN; Yu CJ; Chien YJ; Yang PC;
Respirology; 2009 Sep; 14(7):1012-9. PubMed ID: 19659516
[TBL] [Abstract][Full Text] [Related]
30. Rapid, accurate determination of multidrug resistance in M. tuberculosis isolates and sputum using a biochip system.
Guo Y; Zhou Y; Wang C; Zhu L; Wang S; Li Q; Jiang G; Zhao B; Huang H; Yu H; Xing W; Mitchelson K; Cheng J; Zhao Y
Int J Tuberc Lung Dis; 2009 Jul; 13(7):914-20. PubMed ID: 19555544
[TBL] [Abstract][Full Text] [Related]
31. In vitro drug resistance and response to therapy in pulmonary tuberculosis patients under a DOTS programme in south India.
Aparna SB; Reddy VC; Gokhale S; Moorthy KV
Trans R Soc Trop Med Hyg; 2009 Jun; 103(6):564-70. PubMed ID: 19243801
[TBL] [Abstract][Full Text] [Related]
32. Isoniazid bactericidal activity and resistance emergence: integrating pharmacodynamics and pharmacogenomics to predict efficacy in different ethnic populations.
Gumbo T; Louie A; Liu W; Brown D; Ambrose PG; Bhavnani SM; Drusano GL
Antimicrob Agents Chemother; 2007 Jul; 51(7):2329-36. PubMed ID: 17438043
[TBL] [Abstract][Full Text] [Related]
33. Daily 300 mg dose of linezolid for the treatment of intractable multidrug-resistant and extensively drug-resistant tuberculosis.
Koh WJ; Kwon OJ; Gwak H; Chung JW; Cho SN; Kim WS; Shim TS
J Antimicrob Chemother; 2009 Aug; 64(2):388-91. PubMed ID: 19468028
[TBL] [Abstract][Full Text] [Related]
34. [Epidemiological study on factors affecting the hospitalization period of patients with active tuberculosis].
Fujino T; Fusegawa H; Nishiumi M; Okubo Y; Kakizaki T; Maejima K; Sugimori H
Kekkaku; 2008 Aug; 83(8):567-72. PubMed ID: 18800648
[TBL] [Abstract][Full Text] [Related]
35. [The clinical features of tuberculosis in children and adolescents excreting drug-resistant Mycobacterium tuberculosis strains].
Bekembaeva GS; Serikbaeva KS; Kastypkaeva DV
Probl Tuberk Bolezn Legk; 2009; (6):13-6. PubMed ID: 19642567
[No Abstract] [Full Text] [Related]
36. [Long-term observation of pulmonary Mycobacterium avium complex disease treated with chemotherapy-- following the guidelines for treatment].
Kobashi Y; Oka M
Kekkaku; 2008 Dec; 83(12):779-84. PubMed ID: 19172823
[TBL] [Abstract][Full Text] [Related]
37. [Comparative characteristics of disseminated pulmonary tuberculosis in patients isolating Mycobacterium tuberculosis with a high and low viability].
Koretskaia NM; Iarygina IV
Probl Tuberk Bolezn Legk; 2007; (2):17-20. PubMed ID: 17419328
[TBL] [Abstract][Full Text] [Related]
38. [Development of antituberculous drugs: current status and future prospects].
Tomioka H; Namba K
Kekkaku; 2006 Dec; 81(12):753-74. PubMed ID: 17240921
[TBL] [Abstract][Full Text] [Related]
39. [Mycobacterial tests].
Takashima T; Higuchi T
Kekkaku; 2008 Jan; 83(1):43-59. PubMed ID: 18283915
[TBL] [Abstract][Full Text] [Related]
40. The laboratory as a tool to qualify tuberculosis diagnosis.
Honscha G; Von Groll A; Valença M; Ramos DF; Sanchotene K; Scaini CJ; Ribeiro MO; da Silva PE
Int J Tuberc Lung Dis; 2008 Feb; 12(2):218-20. PubMed ID: 18230257
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
